Toxoplasmosis in Cats: Transmission to Humans and Neurological Manifestations

Introduction

Toxoplasmosis is a globally distributed zoonotic disease caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii [1, 2]. The parasite infects virtually all warm-blooded animals, but felids (domestic and wild cats) serve as the definitive hosts in which the sexual cycle occurs, leading to the excretion of environmentally resistant oocysts [1, 3]. This unique role of cats in the epidemiology of toxoplasmosis makes the infection a significant public health concern [4, 5]. The present article provides a detailed veterinary review of the etiology, epidemiology, transmission pathways to humans, neurological manifestations, pathology, diagnostic approaches, and control strategies for feline toxoplasmosis, with an emphasis on the mechanisms underlying cerebral involvement and the role of oocyst shedding.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within oocysts) [1, 6]. The life cycle is heteroxenous, with cats as the definitive host and a wide range of intermediate hosts, including humans, rodents, birds, and livestock [1, 7]. Cats become infected by ingesting tissue cysts containing bradyzoites from intermediate hosts (e.g., rodents, raw meat) or by ingesting sporulated oocysts from the environment [6, 31]. After ingestion, bradyzoites or sporozoites excyst in the small intestine, invade enterocytes, and undergo asexual multiplication (schizogony) followed by sexual reproduction (gametogony) [1, 6]. The resulting unsporulated oocysts are shed in feces, a process that typically begins 3 to 10 days after primary infection and can last for 1 to 3 weeks [1, 8]. A single cat can excrete millions of oocysts, which sporulate and become infectious within 1 to 5 days under favorable environmental conditions [1, 3]. Sporulated oocysts are highly resistant to environmental degradation and can remain infective for months to years in soil, water, and on surfaces [1, 9].

Epidemiology

Seroprevalence of T. gondii in domestic cats varies widely by geographic region, management practices, and diagnostic methods. Studies using serological assays (e.g., ELISA, IFAT, modified agglutination test) have reported prevalence rates ranging from 6% to over 70% [4, 3, 10, 11, 12, 13, 14, 15, 32, 35]. For example, a study in Kirikkale, Turkey, using immunochromatographic rapid test kits found a 6% prevalence in 50 cats presented to a veterinary hospital [4]. In contrast, a serosurvey in Greece using IFAT reported 20.8% seropositivity among 457 cats, with older age and history of cat-fight trauma identified as risk factors [32]. In Pakistan, stray cats showed a significantly higher infection rate (74.6%) compared to pet cats (25.4%), and older cats (>4 years) had the highest prevalence (91.66%) [15]. A study in western Mexico using Western blot and ELISA found 14.8% seroprevalence, with cats older than one year at increased risk [35]. The prevalence of oocyst shedding in feces is generally lower than seroprevalence, as shedding is transient. In Izmir, Turkey, T. gondii DNA was detected in 14.37% of stray cat feces by real-time PCR, while oocysts were observed microscopically in only 0.43% [8]. These data underscore the importance of environmental contamination by cat feces.

Table 1. Selected seroprevalence studies of T. gondii in domestic cats.

Transmission to Humans: The Role of Toxoplasmosis in Cat Poop

Humans acquire T. gondii infection primarily through three routes: ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with sporulated oocysts, and congenital transmission from mother to fetus [1, 3, 5]. The role of cats in human toxoplasmosis is mediated by the excretion of oocysts in feces, a process directly linked to toxoplasmosis in cat poop [1, 8]. Oocysts shed by cats contaminate soil, gardens, sandboxes, and water sources, and can be inadvertently ingested by humans through unwashed produce, contaminated hands, or inhalation of dust [3, 9]. Stray and free-roaming cats are particularly important reservoirs because they defecate outdoors and have higher infection rates than indoor-only cats [14, 15, 8]. A study in Bangkok found that semi-domesticated cats had 8.34 times higher odds of T. gondii infection than pet cats, and cats living in inner city areas had higher odds than those in suburbs [14]. In Pakistan, stray cats showed a 74.6% infection rate compared to 25.4% in pet cats [15]. The risk of human infection from cat feces is not limited to direct contact; oocysts can be transported by insects, rain runoff, and wind [1]. Proper litter box hygiene, daily removal of feces (before sporulation), and handwashing are critical preventive measures [16, 5]. Pregnant women and immunocompromised individuals are advised to avoid handling cat litter or to use gloves and wash hands thoroughly [5]. The zoonotic risk posed by toxoplasmosis in cat poop is a central theme in public health messaging, as highlighted in related articles such as Toxoplasmosis in Cats: Zoonotic Transmission and Prevention and Toxoplasmosis in Cats: Risks During Pregnancy and Prevention.

Neurological Manifestations: Cat Toxoplasmosis Brain

Neurological signs are among the most clinically significant manifestations of toxoplasmosis in cats, particularly in cases of disseminated or reactivated infection [17, 18, 2, 33]. The term cat toxoplasmosis brain refers to the cerebral involvement that can occur when tachyzoites invade the central nervous system (CNS), causing encephalitis, meningitis, and focal granulomatous lesions [17, 18, 33]. In a retrospective study of 100 histologically confirmed cases of clinical toxoplasmosis in cats, 7% were classified as having predominantly neurologic disease, and T. gondii was identified in 80% of the 55 brains examined [18]. Another study of 126 zoo animal cases (including Pallas' cats, meerkats, and lemurs) found that encephalitis was a common lesion, especially in Pallas' cats and meerkats [33]. Clinical neurological signs reported in cats include seizures, ataxia, circling, head pressing, behavioral changes, blindness, and cranial nerve deficits [17, 18, 2, 33]. Ocular toxoplasmosis often accompanies neurological disease, with multifocal iridocyclochoroiditis being the most common ocular lesion [18, 19, 2]. In a case series of two littermate kittens with acute disseminated toxoplasmosis, neurological signs were prominent and the genotype identified was ToxoDB #4, a wildlife-associated strain [31]. The pathogenesis of CNS toxoplasmosis involves the migration of tachyzoites across the blood-brain barrier, likely via infected leukocytes (Trojan horse mechanism), followed by intracellular replication and host cell lysis, leading to necrosis and inflammation [1, 2]. Reactivation of latent tissue cysts in the brain can occur during immunosuppression, such as concurrent infection with feline immunodeficiency virus (FIV) or feline leukemia virus (FeLV) [10, 2]. For further details on cerebral involvement, see the dedicated article Feline Toxoplasmosis: Neurological Manifestations and Cerebral Involvement.

Pathology

Gross and histopathological lesions of toxoplasmosis in cats are most frequently observed in the lungs, liver, brain, heart, pancreas, and eyes [18, 20, 33]. In a study of 100 cats with histologically confirmed toxoplasmosis, the most common lesion distribution was generalized (36%), followed by pulmonary (26%), abdominal (16%), and neurologic (7%) [18]. Microscopically, lesions consist of necrosis, mononuclear and neutrophilic inflammation, and the presence of tachyzoites or tissue cysts [18, 20]. In the brain, multifocal gliosis, perivascular cuffing, and necrotizing encephalitis are typical [17, 33]. Ocular lesions include iridocyclitis, choroiditis, and retinitis, with tachyzoites often found in the ciliary body and retina [18, 19]. Neonatal toxoplasmosis in kittens, acquired transplacentally or via milk, presents with severe multisystemic lesions including pneumonia, hepatitis, and encephalitis [20, 31].

Diagnosis

Antemortem diagnosis of feline toxoplasmosis relies on a combination of serology, molecular detection, cytology, and histopathology [4, 1, 2, 21]. Serological tests detect anti-T. gondii IgG and IgM antibodies. The modified agglutination test (MAT) using formalin-preserved tachyzoites is considered highly sensitive and specific for cats [22]. Commercial ELISA kits are widely used for screening [4, 3, 15, 35]. A study comparing recombinant antigens SAG2, GRA6, and GRA7 found that GRA7 had the highest sensitivity for serodiagnosis in cats [21]. Immunochromatographic rapid test kits offer a practical, cost-effective option for point-of-care testing [4]. Molecular diagnosis by PCR (conventional or real-time) can detect T. gondii DNA in blood, feces, cerebrospinal fluid, or tissue aspirates, and is particularly useful for confirming active infection [15, 8, 35]. Cytological examination of tracheal wash, bronchoalveolar lavage, or cerebrospinal fluid may reveal tachyzoites [18]. Histopathology with immunohistochemical staining remains the gold standard for postmortem diagnosis [18, 33]. A diagnostic algorithm is presented below.

graph TD
    A[Cat with clinical signs suggestive of toxoplasmosis], > B{Serology (ELISA/MAT/IFAT)}
    B, >|IgG positive, IgM negative| C[Chronic/latent infection]
    B, >|IgG and IgM positive| D[Active or recent infection]
    B, >|Negative| E[Consider other diagnoses]
    D, > F{Confirm with PCR on blood/CSF/feces}
    F, >|Positive| G[Definitive diagnosis of active toxoplasmosis]
    F, >|Negative| H[Consider cytology or biopsy]
    H, >|Tachyzoites seen| G
    H, >|No tachyzoites| I[Empiric treatment based on clinical picture]
    C, > J[No treatment unless immunocompromised or clinical signs]
    G, > K[Initiate antiprotozoal therapy]

Treatment and Control

The primary antiprotozoal agent used for clinical toxoplasmosis in cats is clindamycin, administered at 10-12 mg/kg orally every 12 hours for 2-4 weeks [23, 2, 24]. Clindamycin is effective against tachyzoites but does not eliminate tissue cysts [23]. In a study of experimental acute toxoplasmosis in cats, clindamycin reduced clinical signs but did not prevent oocyst shedding [23]. In Pallas' cats, prophylactic clindamycin reduced juvenile mortality from toxoplasmosis by 67% [24]. Alternative treatments include trimethoprim-sulfonamide combinations and pyrimethamine, though these are less commonly used in cats due to potential adverse effects [2]. Supportive care, including fluid therapy, nutritional support, and management of secondary infections, is essential [2]. Control measures focus on reducing environmental contamination with oocysts. These include: daily removal of cat feces from litter boxes (before sporulation), preventing cats from hunting rodents and birds, feeding only cooked or commercial diets (no raw meat), and controlling stray cat populations [1, 16, 5, 31]. Vaccination of cats against T. gondii is not commercially available, but experimental live attenuated vaccines (e.g., RHΔompdcΔuprt) have shown promise in reducing oocyst shedding by 95.3% in immunized cats [25]. For comprehensive management guidelines, refer to Toxoplasmosis in Cats: Pathogenesis, Zoonotic Transmission, and Management.

Conclusion

Toxoplasmosis in cats remains a significant veterinary and public health concern due to the unique role of felids in shedding oocysts into the environment. Neurological manifestations, including encephalitis and ocular disease, are important clinical presentations, particularly in young, immunocompromised, or genetically susceptible cats. Accurate diagnosis requires a combination of serological, molecular, and histopathological methods. Effective control hinges on responsible pet ownership, hygiene practices, and ongoing research into vaccines and antiprotozoal therapies. The zoonotic risk from toxoplasmosis in cat poop underscores the need for continued public education and veterinary surveillance.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

References

[1] Dubey JP, Cerqueira-Cézar CK, Murata F, et al. All about toxoplasmosis in cats: the last decade. Veterinary Parasitology. 2020. URL: https://www.semanticscholar.org/paper/f0acbbba7cd9f8c048d5d0764bbf9a13fc7c158b

[2] Calero-Bernal R, Gennari SM. Clinical Toxoplasmosis in Dogs and Cats: An Update. Frontiers in Veterinary Science. 2019. URL: https://www.semanticscholar.org/paper/85289202e785e3bc73f8f5115e9316d859714c0c

[3] Fux B, Covre K, Lopes R, et al. Seroprevalence of Toxoplasmosis in Cats in Espirito Santo State, Brazil. Current Developments in Nutrition. 2020. URL: https://www.semanticscholar.org/paper/c8a06a7c2da069a70425a4ee3b10947240fb5aca

[4] Parlatır Y, Şenel Y, Kara E. Determination of the Prevalance of Toxoplasmosis in Cats with Immunochoromatographic Rapid Tests Kits in Kırıkkale University Veterinary Faculty Animal Hospital. Research and Practice in Veterinary and Animal Science. 2025. URL: https://www.semanticscholar.org/paper/247f3db5fd827af96d636da4d3164d751074874f

[5] Hasan MF, Harun A, Hossain D, et al. Toxoplasmosis in animals and humans: a neglected zoonotic disease in Bangladesh. Journal of Parasitic Diseases. 2024. URL: https://www.semanticscholar.org/paper/da821e8fdfc168c67e0410f9698f8797db223dfc

[6] Dubey JP, Frenkel JK. Cyst-induced toxoplasmosis in cats. The Journal of Protozoology. 1972. URL: https://www.semanticscholar.org/paper/12d02c2160648955e5516f3c6df5f8ca6fc8d0c9

[7] Dubey JP. Toxoplasmosis in cats. Journal. 1986. URL: https://www.semanticscholar.org/paper/2d40c71cd859696150a18a7a02da5c18e19cb9f6

[8] Karakavuk M, Can H, Selim N, et al. Investigation of the role of stray cats for transmission of toxoplasmosis to humans and animals living in İzmir, Turkey. Journal of Infection in Developing Countries. 2021. URL: https://www.semanticscholar.org/paper/d4034b4469c570f968226bd0f2428a8841127668

[9] Zakaria R, Ardiansyah S. Potential Analysis Of Toxoplasmosis Distribution In Wild Cats (Felis silvestris) In Some Markets Of Sidoarjo District Through Microscopic Identification Of Toxoplasma gondii. Medicra (Journal of Medical Laboratory Science/Technology). 2020. URL: https://www.semanticscholar.org/paper/82acd479c09d814fba86964b3561af044fa1539a

[10] Munhoz AD, Hage SB, Cruz R, et al. Toxoplasmosis in cats in northeastern Brazil: Frequency, associated factors and coinfection with Neospora caninum, feline immunodeficiency virus and feline leukemia virus. Veterinary Parasitology: Regional Studies and Reports. 2017. URL: https://www.semanticscholar.org/paper/7c8a2fdd2e9561c2569bc4e98397bbe347e630a2

[11] Ahmad N, Ahmed H, Irum S, et al. Seroprevalence of IgG and IgM antibodies and associated risk factors for toxoplasmosis in cats and dogs from sub-tropical arid parts of Pakistan. Tropical Biomedicine. 2014. URL: https://www.semanticscholar.org/paper/da6e18e25d3ce94af78a72a188b4814bde5a4bf6

[12] Al-Kappany YM, Rajendran C, Ferreira LR, et al. High Prevalence of Toxoplasmosis in Cats from Egypt: Isolation of Viable Toxoplasma gondii, Tissue Distribution, and Isolate Designation. Journal of Parasitology. 2010. URL: https://www.semanticscholar.org/paper/eb0cb3755cb9a332123f4cff955b60832811f357

[13] Shahzad A, Khan MS, Ashraf K, et al. Sero-epidemiological and haematological studies on toxoplasmosis in cats, dogs and their owners in Lahore, Pakistan. Journal. 2006. URL: https://www.semanticscholar.org/paper/7d0dfdee60bdf59fcc72a83a2c3ef69c3c975815

[14] Inpankaew T, Sattasathuchana P, Kengradomkij C, et al. Prevalence of toxoplasmosis in semi-domesticated and pet cats within and around Bangkok, Thailand. BMC Veterinary Research. 2021. URL: https://www.semanticscholar.org/paper/9d019b6566281c83eacd73785646da54fbe4f464

[15] Majid A, Ahmad N, Haleem S, et al. Detection of toxoplasmosis in pets and stray cats through molecular and serological techniques in Khyber Pakhtunkhwa, Pakistan. BMC Veterinary Research. 2021. URL: https://www.semanticscholar.org/paper/8d881c294db66470f8cb1039711b82f9beddee6c

[16] Frenkel JK. Toxoplasmosis in cats: diagnosis, treatment and prevention. Comparative Immunology, Microbiology & Infectious Diseases. 1978. URL: https://www.semanticscholar.org/paper/83342586a02084c5abca00f2f74a7c8eaed91493

[17] Cucoș C, Ionașcu I, Mocanu J, et al. Neurological and ocular form of toxoplasmosis in cats. Journal. 2015. URL: https://www.semanticscholar.org/paper/aa122640585a7963211031f376cc4dfc5aad4bb2

[18] Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. 1993. URL: https://www.semanticscholar.org/paper/d52209abc2a6337a4c9d08f712a537010200385e

[19] Vainisi SJ, Campbell LH. Ocular toxoplasmosis in cats. Journal. 1969. URL: https://www.semanticscholar.org/paper/249b39e2a160380e0392f576ba6c852d4525e72d

[20] Dubey JP, Mattix ME, Lipscomb TP. Lesions of Neonatally Induced Toxoplasmosis in Cats. Veterinary Pathology-Supplement. 1996. URL: https://www.semanticscholar.org/paper/1254e6ad6e3a8af547409537637842df2c9baaf2

[21] Sabukunze S, Gu H, Zhao L, et al. Comparison of the performance of SAG2, GRA6, and GRA7 for serological diagnosis of Toxoplasma gondii infection in cats. Frontiers in Veterinary Science. 2024. URL: https://www.semanticscholar.org/paper/9f5d168c43119aed8d92f0b3115eb05d8db3dc99

[22] Dubey JP, Thulliez P. Serologic diagnosis of toxoplasmosis in cats fed Toxoplasma gondii tissue cysts. Journal of the American Veterinary Medical Association. 1989. URL: https://www.semanticscholar.org/paper/ee22536cb0d4e9d5bd35bdcff522943c207f2843

[23] Davidson MG, Lappin MR, Rottman JR, et al. Paradoxical effect of clindamycin in experimental, acute toxoplasmosis in cats. Antimicrobial Agents and Chemotherapy. 1996. URL: https://www.semanticscholar.org/paper/3c33146daf33215dac6e658719c1d07bb266fdf7

[24] Girling SJ, Pizzi R, Naylor A, et al. USE OF CLINDAMYCIN IN PALLAS' CAT

[25] Shen Y, Zheng B, Sun H, et al. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats. Infectious Diseases of Poverty. 2023. URL: https://www.semanticscholar.org/paper/2c0eccd9ce92a1acbb4617baa6621f2d56e59c8e

[26] Dubey JP, Hoover EA, Walls KW. Effect of age and sex on the acquisition of immunity to toxoplasmosis in cats. The Journal of Protozoology. 1977. URL: https://www.semanticscholar.org/paper/23dc34fe496f694a558cf945c5ed25693529c1dd

[27] Zafar ZUA, Ali N, Baleanu D. Dynamics and numerical investigations of a fractional-order model of toxoplasmosis in the population of human and cats. Journal. 2021. URL: https://www.semanticscholar.org/paper/db91c7fb65e1a1d56be21460221b7855e2809a5c

[28] Germano PML, Melo HFA, Bianchin I, et al. Toxoplasmosis in cats and dogs. Journal. 1980. URL: https://www.semanticscholar.org/paper/28ba5dd1a8560109667f0cde4939e26be92466a8

[29] Bastan I. Clinical and some laboratory findings in cats with Toxoplasmosis. Journal. 2018. URL: https://www.semanticscholar.org/paper/22a23aba5dc5ed1ccad8996586a2a1622e64a857

[30] Vinogradov LI. Diagnosis of toxoplasmosis in cats. Journal. 1980. URL: https://www.semanticscholar.org/paper/547f904162fe1e9133e7b8fbdd7c56c7fd520f18